Cargando…
Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy
BACKGROUND: [(18)F]Fludarabine is a novel positron emission tomography (PET) radiotracer for imaging lymphoma. The purpose of this preclinical study was to evaluate the robustness of [(18)F]fludarabine during rituximab therapy. In addition, a comparison was made between [(18)F]fludarabine and [(18)F...
Autores principales: | Hovhannisyan, Narinée, Guillouet, Stéphane, Fillesoye, Fabien, Dhilly, Martine, Patin, Delphine, Galateau, Françoise, Leporrier, Michel, Barré, Louisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414862/ https://www.ncbi.nlm.nih.gov/pubmed/25977881 http://dx.doi.org/10.1186/s13550-015-0101-7 |
Ejemplares similares
-
[(18)F]Fludarabine-PET in a murine model of multiple myeloma
por: Hovhannisyan, Narinée, et al.
Publicado: (2017) -
[(18)F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [(18)F]FDG in human xenograft models
por: Hovhannisyan, Narinée, et al.
Publicado: (2018) -
[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019) -
A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016) -
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [(18)F]FDG and sodium [(18)F]fluoride PET
por: Collantes, María, et al.
Publicado: (2018)